Bharat Parenterals Ltd Share Price

Q: What is the share price of Bharat Parenterals Ltd today?

Bharat Parenterals Ltd share price as on 18 Jul 2026 is ₹0

Pharmaceuticals

BSE: 541096 Small Cap ISIN: INE365Y01019

As on 18 July 2026 at 17:02 IST

Stock Not Traded in BSE

Over 1 Month

6.25%

Over 6 Months

24.81%

Over 1 Year

4.45%

Over 3 Years

256.11%

Bharat Parenterals Ltd Summary

Close ₹1,324.20

Open ₹1,339.60

High ₹1,345

Low ₹1,300

Volume 821

Net Turnover (in Cr) ₹0.1

52Wk High ₹1,667.20

52Wk Low ₹880.25

52Wk High / Low

880.25

1,667.20

Bharat Parenterals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹912.63

EPS (TTM) 23.24

Book Value (BV) 583.78

Div. Yield 0.08 %

P/E (TTM) 56.98

Price/Book Value 2.27

Delivery % 75.88 %

Face Value 10

Key Ratios

PE Ratio 25.73

PB Ratio 1.76

EV to Sales 2.36

PEG Ratio -22.70

ROA 5.79

ROE 8.81

Debt-Equity 0.24

Net Profit Margin 8.70

Operating Profit Margin 15.84

Bharat Parenterals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	352	265.90	229.72	219.79	213.32
Total Expenses	385.95	247.17	206.17	191.92	186.19
Profit Before Tax	-33.95	18.72	23.55	27.88	27.12
Profit After Tax	-43.68	10.51	15.71	20.81	20.32
Operating Profit After Depreciation	-21	22.74	25.73	28.77	27.52

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	252.16	210.75	41.19	39.75	43.36
Total Non Current Assets	293.01	242.04	166.06	82.32	50.63
Total Current Assets	355.52	262	184.28	143.74	148.02
Total Assets	648.53	504.04	350.34	226.06	198.65
Total Shareholder's Fund	330.67	197.27	182.80	165.82	143.87

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-27.25	-4.71	21.66	-1.07	24.45
Net Cash Used In Investing Activities	-137.38	-104.78	-77.82	-6.63	-43.37
Net Cash Used In Financing Activities	156.37	110.43	60.60	9.42	10.50

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	318.68	266.02	236.82	219.79	212.34
Total Expenses	282.37	235.22	204.65	191.42	185.32
Profit Before Tax	36.32	30.80	32.17	28.37	27.02
Profit After Tax	26.45	22.59	24.34	21.30	20.21
Operating Profit After Depreciation	41.10	34.60	34.36	29.34	27.78

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	45.37	38.47	35.28	39.75	43.36
Total Non Current Assets	283.41	166.84	133.51	74.64	49.21
Total Current Assets	265.78	220.31	174.51	143.36	147.02
Total Assets	549.19	387.15	308.03	218	196.24
Total Shareholder's Fund	386.83	213.61	191.06	166.15	143.94

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	19.22	-0.16	-11.56	-22.08	29.67
Net Cash Used In Investing Activities	-89.69	-38.19	-13.95	21.76	-46.27
Net Cash Used In Financing Activities	69.25	33.51	28.52	2.24	8.31

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	99.62	65.19	64.62	116	103.98
Total Expenses	100.15	63.44	63.80	102.22	101.74
Profit Before Tax	-8.38	-8.28	-7.32	2.55	-8.29
Profit After Tax	-8.16	-9.67	-8.60	-0.87	-9.44
Operating Profit after Depreciation	3.10	3.08	4.35	14.84	4.17

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	56.54	41.41	41.70	94.37	80.28
Total Expenses	56.50	37.94	39.36	79.11	75.69
Profit Before Tax	1.93	3.10	3.42	13.40	3.55
Profit After Tax	1.38	1.92	2.73	10	2.28
Operating Profit after Depreciation	4.48	5.75	6.55	16.88	6.85

Bharat Parenterals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,301.13

S2 1,278.07

S3 1,256.13

Pivot 1,323.07

R1 1,346.13

R2 1,368.07

R3 1,391.13

Moving Average

20 SMA 1,318.69

50 SMA 1,235.53

100 SMA 1,146.82

200 SMA 1,190.43

Bharat Parenterals Ltd Corporate Actions

Bharat Parenterals Ltd

₹1.0/Share

Announcement Date 19 Sep 2025

Record Date 19 Sep 2025

Div Yield 10%

AGM Date: 30 Sep 2021

AGM 30/09/2021 As per the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, proceedings of the 28th Annual General Meeting held on 30th September, 2021 through Video Conferencing (VC)/Other audio visual means (OAVM) of the Company is enclosed herewith. (As per BSE Announcement Dated on 30/09/2021) Pursuant to regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,2015 as amended, enclosed herewith the details of Voting results and Scrutinizer Report of 28th Annual General Meeting of the company held through Video Conferencing or Other Audio-Visual Means (OAVM) on 30th September,2021 at 01:00 P.M. (As Per BSE announcement Dated on 01.10.2021) Pursuant to regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulations2015 as amended enclosed herewith the details of Voting results and Scrutinizer Report of 28th Annual General Meeting of the company held through Video Conferencing or Other Audio-Visual Means (OAVM) on 30th September2021 at 01:00 P.M. (As Per BSE Announcement Dated on 10/2/2021 9:36:36 AM)

AGM Date: 27 Sep 2022

AGM 27/09/2022 We submit herewith 29th Annual Report of the company for the FY 2021-2022 together with the Notice of 29th Annual General Meeting of the company scheduled to be held on 27th September, 2022 at 10:30 A.M. through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by Ministry of Corporate Affairs (MCA) and SEBI. The said Annual Report along with the Notice is also available on the website of the company www.bplindia.in A copy of the Annual Report is being mailed to all the shareholders of the company whose E-Mails IDs are registered with the company/R&T Agents & DPs. We wish to inform you that 29th Annual General Meeting ('AGM') of the Company will be held on Tuesday, September 27,2022 at 10:30 A.M. (IST) at its Registered Office through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by Ministry of Corporate Affairs (MCA) and SEBI. Pursuant to Regulation 30 and 34 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith notice convening the 29th Annual General Meeting (As Per BSE Announcement dated on 02.09.2022) As per the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, proceedings of the 29th Annual General Meeting held on 27th September, 2022 through Video Conferencing (VC)/other audio visual means (OAVM) of the Company is enclosed herewith. (As Per BSE Announcement dated on 27.09.2022) Pursuant to regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,2015 as amended, enclosed herewith the details of Voting results and Scrutinizer Report of 29th Annual General Meeting of the company held through Video Conferencing or Other Audio-Visual Means (OAVM) on 27th September,2022 at 10:30 A.M. (As per BSE Announcement Dated on 28/9/2022) In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following resolutions are approved in the 29th Annual General Meeting of the company held on 27th September, 2022 (As per BSE Announcement Dated on 11/10/2022) In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following resolutions are approved in the 29th Annual General Meeting of the company held on 27th September, 2022: 1. Reappointment of Statutory Auditors CNK & Associates LLP, Chartered accountants (ICAI Firm Registration No. 101961) for the second term of 5 years. 2. Approval of material related party transactions. 3. Approval of Increase in Authorized Share Capital of the company by Rs. 50,00,000/- (Rupees Fifty Only) divided into 5,00,000 (Five Lakhs) Equity Shares of Rs. 10/- (Rupees Ten Only) each and alteration of Memorandum of Association of the Company. 4. Reappointment of Mrs. Zankhana Sheth, Independent Director of the company. 5. Approval of Loans, Investment, Guarantee or security to be made under section 185 of Companies Act, 2013 to subsidiary company 'Varenyam Biolifesciences Private Limited' (As Per BSE Announcement Dated on 14.10.2022)

AGM Date: 30 Sep 2023

AGM 30/09/2023 We hereby submit the Notice of 30th AGM alongwith the Annual Report for the Financial Year 2022-23 of the Company. (As Per BSE Announcement Dated on 05.09.2023) Enclosed herewith the Proceedings of AGM held on 30.09.2023. (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 02 Jul 2024

AGM 02/07/2024 The Intimation of 31st Annual General Meeting is Scheduled on 2nd July, 2024 and Record date/Cut off date as fixed for final dividend for FY 2023-2024 Intimation of Cut off date for E-voting for 31st Annual General Meeting of the Company (As Per BSE Announcement dated on 10.06.2024) Intimation of Revised Annual report fo fiancial year and quarter ended on 31st March, 2024. (As Per BSE Announcement dated on 25.06.2024) Proceedings/Transcript of 31st Annual General Meeting held on 2nd July,2024 (As Per BSE Announcement Dated on: 02/07/2024) Intimation of Voting result alongwith Scrutinizer''s report for 31st Annual General Meeting held on 2nd July, 2024 (As Per BSE Announcement Dated on 04.07.2024)

AGM Date: 26 Sep 2025

AGM 26/09/2025 Please find enclosed Notice of the 32nd Annual General Meeting of the company to be held on Friday, September 26, 2025, at 11:00 A.M (IST) through Video conferencing / other Audio-visual Means. (As per BSE Announcement Dated on 04.09.2025) Intimation of Book Closure (As per BSE Announcement Dated on 04.09.2025) Intimation of Proceedings of the 32nd Annual General Meeting of the company held on September 26, 2025. (As Per Bse Announcement dated on 26/09/2025) Voting results along with the Scrutinizer report. (As per BSE Announcement dated on: 27/09/2025)

Bharat Parenterals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Bharat Parenterals Ltd Top Mutal Funds Invested

No data available

Bharat Parenterals Ltd News

Board of Bharat Parenterals recommends Final Dividend

Of Rs.1 per share

18 May 2026, 05:20 pm

Bharat Parenterals to announce Quarterly Result

On 18 May 2026

09 May 2026, 04:14 pm

Bharat Parenterals arm Innoxel gets 5 observations after USFDA inspection

Bharat Parenterals said that its subsidiary, Innoxel Lifesciences, underwent a surprise inspection by the United States Food and Drug Administration (USFDA) at its finished dosage manufacturing facility in Vadodara, Gujarat.

21 Apr 2026, 03:30 pm

Bharat Parenterals announces board meeting date

On 30 January 2026

22 Jan 2026, 05:56 pm

Bharat Parenterals announces board meeting date

On 12 November 2025

07 Nov 2025, 03:27 pm

Bharat Parenterals Ltd Stock Analysis

Annual revenue for Bharat Parenterals Ltd increased by 19.79% to ₹318.68 crore in FY 2025 from ₹266.02 crore in FY 2024.
Annual Net Profit for Bharat Parenterals Ltd increased by 17.08% to ₹26.45 crore in FY 2025 from ₹22.59 crore in FY 2024.
Promoter Shareholding in Bharat Parenterals Ltd decreased by 0.04% in the most recent quarter, from 67.19% in December 2025 to 67.17% in March 2026.
Bharat Parenterals Ltd delivered a 1-year return of 4.45% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Bharat Parenterals Ltd share price moved down by 100.00% from its previous close of INR ₹1,324.20. The latest Bharat Parenterals Ltd share price is INR ₹0.
Bharat Parenterals Ltd share price today has been at a low of 1,300 and a high of 1,345. Over the past 52 weeks, the Bharat Parenterals Ltd share price has seen a low of 880.25 and a high of 1,667.20.